Showing results (421-430 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|December 28, 2007
Phase II trial of lenalidomide in patients with metastatic renal cell carcinomaPremal H Patel, G Varuni Kondagunta, Lawrence Schwartz, et al.
Investigational New Drugs|February 1, 2008
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urotheliumThomas E Hutson, Svetislava Vukelja, Daniel Atienza, et al.
Investigational New Drugs|February 1, 1993
A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogarilG R Weiss, T D Brown, J G Kuhn, et al.
Investigational New Drugs|February 1, 1993
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancerD G Pfister, D Bajorin, R J Motzer, et al.
Investigational New Drugs|February 1, 1993
Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinomaJ A Ajani, J L Abbruzzese, A B Markowitz, et al.
Investigational New Drugs|February 1, 1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancerN Ben-Baruch, A M Denicoff, B R Goldspiel, et al.
Investigational New Drugs|January 1, 1995
Preclinical pharmacokinetics and antitumor activity of imexonR T Dorr, J D Liddil, M K Klein, et al.
Investigational New Drugs|January 1, 1995
Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588)A Y Chang, Z N Tu, J L Smith, et al.
Investigational New Drugs|January 1, 1995
A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinomaN J Meropol, N J Petrelli, Y M Rustum, et al.
Investigational New Drugs|January 1, 1995
Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumorsH S Puc, D F Bajorin, G J Bosl, et al.
Pageof 372